| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access and quality of biomarker testing for precision oncology in Europe
|
Normanno, Nicola
|
|
|
176 |
C |
p. 70-77
|
artikel
|
| 2 |
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
|
Khattak, Muhammad A.
|
|
|
176 |
C |
p. 207-217
|
artikel
|
| 3 |
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
|
Rosenbaum, Evan
|
|
|
176 |
C |
p. 155-163
|
artikel
|
| 4 |
Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer
|
Kim, Dae Won
|
|
|
176 |
C |
p. 171-180
|
artikel
|
| 5 |
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study
|
Houvenaeghel, Gilles
|
|
|
176 |
C |
p. 58-69
|
artikel
|
| 6 |
DeepClassPathway: Molecular pathway aware classification using explainable deep learning
|
Lombardo, Elia
|
|
|
176 |
C |
p. 41-49
|
artikel
|
| 7 |
Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
|
Di Noia, Vincenzo
|
|
|
176 |
C |
p. 164-167
|
artikel
|
| 8 |
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients
|
Nakamura, Yasuhiro
|
|
|
176 |
C |
p. 78-87
|
artikel
|
| 9 |
Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy
|
Evans, Joanne S.
|
|
|
176 |
C |
p. 110-120
|
artikel
|
| 10 |
FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope?
|
Helal, Clara
|
|
|
176 |
C |
p. 168-170
|
artikel
|
| 11 |
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation
|
Unterrainer, Marcus
|
|
|
176 |
C |
p. 193-206
|
artikel
|
| 12 |
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis
|
Meeuwes, Frederik O.
|
|
|
176 |
C |
p. 100-109
|
artikel
|
| 13 |
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)
|
Bielack, Stefan S.
|
|
|
176 |
C |
p. 50-57
|
artikel
|
| 14 |
Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy
|
Kang, Sora
|
|
|
176 |
C |
p. 30-40
|
artikel
|
| 15 |
Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers
|
de Nonneville, Alexandre
|
|
|
176 |
C |
p. 181-188
|
artikel
|
| 16 |
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life
|
Schulz, Thomas U.
|
|
|
176 |
C |
p. 88-99
|
artikel
|
| 17 |
Proxalutamide in patients with AR-positive metastatic breast cancer: Results from an open-label multicentre phase Ib study and biomarker analysis
|
Jiang, Hanfang
|
|
|
176 |
C |
p. 1-12
|
artikel
|
| 18 |
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study
|
Serra-Bellver, Patricio
|
|
|
176 |
C |
p. 121-132
|
artikel
|
| 19 |
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma
|
Moehler, Markus
|
|
|
176 |
C |
p. 13-29
|
artikel
|
| 20 |
Regression of intestinal diffuse large B cell lymphoma after treatment with vedolizumab in a patient with Crohn's disease
|
Yamamoto, Shuji
|
|
|
176 |
C |
p. 189-192
|
artikel
|
| 21 |
The clinical utility of dysregulated microRNA expression in paediatric solid tumours
|
Chadda, Karan R.
|
|
|
176 |
C |
p. 133-154
|
artikel
|
Tijdschrift beschrijving